206 related articles for article (PubMed ID: 7586800)
21. Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway.
Makowski GS; Ramsby ML
Inflammation; 1998 Jun; 22(3):287-305. PubMed ID: 9604716
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of human collagenase activity by antisense oligonucleoside methylphosphonates.
Delong RK; Miller PS
Antisense Nucleic Acid Drug Dev; 1996; 6(4):273-80. PubMed ID: 9012863
[TBL] [Abstract][Full Text] [Related]
23. Production of matrix metalloproteinases 2 and 3 (stromelysin) by stromal cells of giant cell tumor of bone.
Sasaguri Y; Komiya S; Sugama K; Suzuki K; Inoue A; Morimatsu M; Nagase H
Am J Pathol; 1992 Sep; 141(3):611-21. PubMed ID: 1519668
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.
Afzal S; Lalani el-N ; Foulkes WD; Boyce B; Tickle S; Cardillo MR; Baker T; Pignatelli M; Stamp GW
Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160
[TBL] [Abstract][Full Text] [Related]
25. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
Duivenvoorden WC; Hirte HW; Singh G
Invasion Metastasis; 1997; 17(6):312-22. PubMed ID: 9949290
[TBL] [Abstract][Full Text] [Related]
26. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis.
Sato H; Seiki M
J Biochem; 1996 Feb; 119(2):209-15. PubMed ID: 8882706
[TBL] [Abstract][Full Text] [Related]
27. Expression of 72-kDa gelatinase (MMP-2), collagenase (MMP-1), and tissue metalloproteinase inhibitor (TIMP) in primary pig skin fibroblast cultures derived from radiation-induced skin fibrosis.
Lafuma C; El Nabout RA; Crechet F; Hovnanian A; Martin M
J Invest Dermatol; 1994 Jun; 102(6):945-50. PubMed ID: 8006459
[TBL] [Abstract][Full Text] [Related]
28. Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung.
Kodate M; Kasai T; Hashimoto H; Yasumoto K; Iwata Y; Manabe H
Pathol Int; 1997 Jul; 47(7):461-9. PubMed ID: 9234385
[TBL] [Abstract][Full Text] [Related]
29. Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors.
Gokaslan ZL; Chintala SK; York JE; Boyapati V; Jasti S; Sawaya R; Fuller G; Wildrick DM; Nicolson GL; Rao JS
Clin Exp Metastasis; 1998 Nov; 16(8):721-8. PubMed ID: 10211985
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase expression in human retinal microvascular cells.
Grant MB; Caballero S; Tarnuzzer RW; Bass KE; Ljubimov AV; Spoerri PE; Galardy RE
Diabetes; 1998 Aug; 47(8):1311-7. PubMed ID: 9703333
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis.
Sugiura Y; Shimada H; Seeger RC; Laug WE; DeClerck YA
Cancer Res; 1998 May; 58(10):2209-16. PubMed ID: 9605768
[TBL] [Abstract][Full Text] [Related]
32. Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumour necrosis factor alpha correlates with metastatic ability in a human osteosarcoma cell line.
Kawashima A; Nakanishi I; Tsuchiya H; Roessner A; Obata K; Okada Y
Virchows Arch; 1994; 424(5):547-52. PubMed ID: 8032535
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
Romanic AM; White RF; Arleth AJ; Ohlstein EH; Barone FC
Stroke; 1998 May; 29(5):1020-30. PubMed ID: 9596253
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma.
Yoshizaki T; Sato H; Maruyama Y; Murono S; Furukawa M; Park CS; Seiki M
Cancer; 1997 Jan; 79(1):139-44. PubMed ID: 8988738
[TBL] [Abstract][Full Text] [Related]
35. Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells.
Abbas Abidi SM; Howard EW; Dmytryk JJ; Pento JT
Clin Exp Metastasis; 1997 Jul; 15(4):432-9. PubMed ID: 9219732
[TBL] [Abstract][Full Text] [Related]
36. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.
Abe T; Mori T; Kohno K; Seiki M; Hayakawa T; Welgus HG; Hori S; Kuwano M
Clin Exp Metastasis; 1994 Jul; 12(4):296-304. PubMed ID: 8039304
[TBL] [Abstract][Full Text] [Related]
37. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments.
Aimes RT; Quigley JP
J Biol Chem; 1995 Mar; 270(11):5872-6. PubMed ID: 7890717
[TBL] [Abstract][Full Text] [Related]
39. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9.
Ochieng J; Fridman R; Nangia-Makker P; Kleiner DE; Liotta LA; Stetler-Stevenson WG; Raz A
Biochemistry; 1994 Nov; 33(47):14109-14. PubMed ID: 7947821
[TBL] [Abstract][Full Text] [Related]
40. Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of lung.
Nakagawa H; Yagihashi S
Jpn J Cancer Res; 1994 Sep; 85(9):934-8. PubMed ID: 7961122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
